Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroVentures is a specialized venture capital firm dedicated to investing in and building companies focused on the central nervous system (CNS) and neuroscience. Founded by industry veterans with deep expertise in neurology, the firm provides both capital and strategic guidance to early-stage biotechnology and medical device companies. Their investment strategy targets breakthrough therapies and technologies for high-unmet-need conditions such as Alzheimer's, Parkinson's, and chronic pain. By leveraging a network of scientific advisors and industry partners, NeuroVentures aims to accelerate the development of transformative treatments for neurological and psychiatric disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro Ventures.